Cellular mechanisms of insulin resistance in humans

American Journal of Cardiology

Volumn 84, Issue 1 A, 1999, Pages 3-10

  Shulman, Gerald I ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; FATTY ACID; INSULIN RECEPTOR; METFORMIN; SULFONYLUREA DERIVATIVE; TROGLITAZONE;

CARBON NUCLEAR MAGNETIC RESONANCE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT SYSTEM; GLYCOGEN LIVER LEVEL; GLYCOGEN MUSCLE LEVEL; GLYCOGEN SYNTHESIS; HUMAN; INSULIN RESISTANCE; LIVER METABOLISM; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033536157     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00350-1     Document Type: Conference Paper

References (28)

1. Warram J.H., Martin B.C., Krolewski A.S., Soeldner J.S., Kahn C.R. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic patients. Ann Intern Med. 113:1990;909-915.
2. Lillioja S., Mott D.M., Howard B.V., Bennett P.H., Yki-Jarvinen H., Freymond D., Nyomba B.L., Zurlo F., Swinburn B., Bogardus C. Impaired glucose tolerance as a disorder of insulin action longitudinal and cross-sectional studies in Pima Indians . N Engl J Med. 318:1988;1217-1225.
3. Haffner S.M., Stern M.P., Dunn J., Mobley M., Blackwell J., Bergman R.N. Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans. Metabolism. 39:1990;842-847.
4. Reaven G.M., Bernstein R., Davis B., Olefsky J.M. Nonketotic diabetes mellitus insulin deficiency or insulin resistance? Am J Med. 60:1976;80-88.
5. DeFronzo R.A. The triumvirate beta-cell, muscle, liver: a collusion responsible for NIDDM . Diabetes. 37:1988;667-687.
6. Cahill G.F. Jr. Beta-cell deficiency, insulin resistance, or both? [Editorial]. N Engl J Med. 318:1988;1268-1270.
7. 13C nuclear magnetic resonance spectroscopy. N Engl J Med. 322:1990;223-228.
8. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus . J Clin Invest. 89:1992;1069-1075.
9. Rothman D.L., Magnusson I., Cline G., Gerard D., Kahn C.R., Shulman R.G., Shulman G.I. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA. 92:1995;983-987.
10. Rossetti L., Giaccari A., DeFronzo R.A. Glucose toxicity. Diabetes Care. 13:1990;610-630.
11. Kobberling J., Tillil H. Empirical risk figures for first-degree relatives of non-insulin-dependent diabetics. Kobberling J., Tattersall R. The Genetics of Diabetes Mellitus. 1982;202-209 Academic Press, London.
12. Reaven G.M., Hollenbeck C., Jeng C.-Y., Wu M.S., Chen Y.-D. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24h in patients with NIDDM. Diabetes. 37:1988;1020-1024.
13. Frayne K.N. Insulin resistance and lipid metabolism. Curr Opin Lipidol. 4:1993;197-204.
14. Steiner G., Morita S., Vranic M. Resistance to insulin but not to glucagon in lean human hypertriglyceridemia. Diabetes. 29:1980;899-905.
15. Perseghin G., Ghosh S., Gerow K., Shulman G.I. Metabolic defects in lean nondiabetic offspring of NIDDM parents a cross-sectional study . Diabetes. 46:1997;1001-1009.
16. Randle P.J., Garland P.B., Hales C.N., Newsholme E.A. The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus . Lancet. i:1963;785-789.
17. Randle P.G., Garland P.B., Newsholme E.A., Hales C.N. The glucose fatty-acid cycle in obesity and maturity onset diabetes mellitus. Ann N Y Acad Sci. 131:1965;324-333.
18. Roden M., Price T.B., Perseghin G., Petersen K.F., Rothman D.L., Cline G.W., Shulman G.I. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 97:1996;2859-2865.
19. Randle P.J., Newsholme E.A., Garland P.B. Regulation of glucose uptake by muscle 8 effects of fatty acids, ketone bodies and pyruvate, and of alloxan, diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles . Biochem J. 93:1964;652-665.
20. Randle P.J., Priestman D.A., Mistry S., Halsall A. Mechanisms modifying glucose oxidation in diabetes mellitus. Diabetologia. 37:(suppl 2):1994;S155-S161.
21. Dresner A., Laurent D., Marcucci M., Griffin M.E., Dufour S., Cline G.W., Slezak L.A., Andersen D.K., Hundal R.S., Rothman D.L., Petersen K.F., Shulman G.I. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest. 103:1999;253-259.
22. 13C NMR. Science. 254:1991;573-576.
23. Petersen K.F., Price T., Cline G.W., Rothman D.L., Shulman G.I. Contribution of net hepatic glycogenolysis to glucose production during the early postprandial period. Am J Physiol. 270:1996;E186-E191.
24. 13C nuclear magnetic resonance study . J Clin Invest. 90:1992;1323-1327.
25. Maggs D.G., Buchanan T.A., Burant C.F., Cline G., Gumbiner B., Hsueh W.A., Inzucchi S., Kelley D., Nolan J., Olefsky J.M., et al. Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus a randomized, double-blind, placebo-controlled trial . Ann Intern Med. 128:1998;176-185.
26. Johnson A.B., Webster J.M., Sum C.-F., Heseltine L., Argyraki M., Cooper B.G., Taylor R. The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients. Metabolism. 42:1993;1217-1222.
27. Perriello G., Misericordia P., Volpi E., Santucci A., Santucci C., Ferrannini E., Ventura M.M., Santeusanio F., Brunetti P., Bolli G.B. Acute antihyperglycemic mechanisms of metformin in NIDDM evidence for suppression of lipid oxidation and hepatic glucose production . Diabetes. 43:1994;920-928.
28. Inzucchi S.E., Maggs D.G., Spollett G.R., Page S.L., Rife F.S., Walton V., Shulman G.I. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med. 338:1998;867-872.